Smoking and Activated Clotting Time during coronary angiography and angioplasty: protocol for the ACT-Tobacco trial

BACKGROUND: During percutaneous transluminal coronary angioplasty (PTCA), activated clotting time (ACT) measurements are recommended to attest a correct anticoagulation level and, if needed, to administer further unfractionated heparin (UFH) to obtain a therapeutic ACT value. Our clinical routine le...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimolé, Régis, Manzi, Hugo, Hosseini, Kossar, Remen, Thomas, Toussaint-Hacquard, Marie, Camenzind, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005900/
https://www.ncbi.nlm.nih.gov/pubmed/36915865
http://dx.doi.org/10.1016/j.rpth.2023.100083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005900/
https://www.ncbi.nlm.nih.gov/pubmed/36915865
http://dx.doi.org/10.1016/j.rpth.2023.100083

Ejemplares similares